These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24561431)

  • 41. High Wilms' tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m
    Naren D; Yan T; Gong Y; Huang J; Zhang D; Sang L; Zheng X; Li Y
    J Cancer Res Clin Oncol; 2021 Jan; 147(1):33-47. PubMed ID: 32880751
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PRDM16 isoforms differentially regulate normal and leukemic hematopoiesis and inflammatory gene signature.
    Corrigan DJ; Luchsinger LL; Justino de Almeida M; Williams LJ; Strikoudis A; Snoeck HW
    J Clin Invest; 2018 Aug; 128(8):3250-3264. PubMed ID: 29878897
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Profiling of histone H3 lysine 9 trimethylation levels predicts transcription factor activity and survival in acute myeloid leukemia.
    Müller-Tidow C; Klein HU; Hascher A; Isken F; Tickenbrock L; Thoennissen N; Agrawal-Singh S; Tschanter P; Disselhoff C; Wang Y; Becker A; Thiede C; Ehninger G; zur Stadt U; Koschmieder S; Seidl M; Müller FU; Schmitz W; Schlenke P; McClelland M; Berdel WE; Dugas M; Serve H;
    Blood; 2010 Nov; 116(18):3564-71. PubMed ID: 20498303
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients.
    Hoang VT; Buss EC; Wang W; Hoffmann I; Raffel S; Zepeda-Moreno A; Baran N; Wuchter P; Eckstein V; Trumpp A; Jauch A; Ho AD; Lutz C
    Int J Cancer; 2015 Aug; 137(3):525-36. PubMed ID: 25545165
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vitamin D Receptor Controls Cell Stemness in Acute Myeloid Leukemia and in Normal Bone Marrow.
    Paubelle E; Zylbersztejn F; Maciel TT; Carvalho C; Mupo A; Cheok M; Lieben L; Sujobert P; Decroocq J; Yokoyama A; Asnafi V; Macintyre E; Tamburini J; Bardet V; Castaigne S; Preudhomme C; Dombret H; Carmeliet G; Bouscary D; Ginzburg YZ; de Thé H; Benhamou M; Monteiro RC; Vassiliou GS; Hermine O; Moura IC
    Cell Rep; 2020 Jan; 30(3):739-754.e4. PubMed ID: 31968250
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Methylation-independent ITGA2 overexpression is associated with poor prognosis in de novo acute myeloid leukemia.
    Lian XY; Zhang W; Wu DH; Ma JC; Zhou JD; Zhang ZH; Wen XM; Xu ZJ; Lin J; Qian J
    J Cell Physiol; 2018 Dec; 233(12):9584-9593. PubMed ID: 30132837
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The epigenome of AML stem and progenitor cells.
    Yamazaki J; Estecio MR; Lu Y; Long H; Malouf GG; Graber D; Huo Y; Ramagli L; Liang S; Kornblau SM; Jelinek J; Issa JP
    Epigenetics; 2013 Jan; 8(1):92-104. PubMed ID: 23249680
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression and functional relevance of long non-coding RNAs in acute myeloid leukemia stem cells.
    Bill M; Papaioannou D; Karunasiri M; Kohlschmidt J; Pepe F; Walker CJ; Walker AE; Brannan Z; Pathmanathan A; Zhang X; Mrózek K; LaRocco A; Volinia S; Bloomfield CD; Garzon R; Dorrance AM
    Leukemia; 2019 Sep; 33(9):2169-2182. PubMed ID: 30858548
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Neoplastic mastocytosis evolving from a poor prognosis acute myeloid leukemia].
    Chen-Liang TH; Jerez A; Florensa L; Ortuño FJ
    Med Clin (Barc); 2015 Jun; 144(12):571-2. PubMed ID: 25249393
    [No Abstract]   [Full Text] [Related]  

  • 50. [Acute myeloid leukemia: from risk-adapted to genotype-specific therapy].
    Kayser S; Schlenk RF
    Dtsch Med Wochenschr; 2011 Aug; 136(31-32):1577-80. PubMed ID: 21809245
    [No Abstract]   [Full Text] [Related]  

  • 51. Clinical applications of epigenetic markers and epigenetic profiling in myeloid malignancies.
    McDevitt MA
    Semin Oncol; 2012 Feb; 39(1):109-22. PubMed ID: 22289497
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of distinctive long noncoding RNA competitive interactions and a six-methylated-gene prognostic signature in acute myeloid leukemia with -5/del(5q) or -7/del(7q).
    Yin X; Huang S; Xu A; Fan F; Chen L; Sun C; Hu Y
    J Cell Biochem; 2020 Feb; 121(2):1563-1574. PubMed ID: 31535409
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of the myeloperoxidase gene in AC133 positive leukemia cells relates to the prognosis of acute myeloid leukemia.
    Taguchi J; Miyazaki Y; Tsutsumi C; Sawayama Y; Ando K; Tsushima H; Fukushima T; Hata T; Yoshida S; Kuriyama K; Honda S; Jinnai I; Mano H; Tomonaga M
    Leuk Res; 2006 Sep; 30(9):1105-12. PubMed ID: 16457884
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Humanized model to study leukemic stem cells.
    Bonnet D
    Methods Mol Biol; 2009; 538():247-62. PubMed ID: 19277589
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nucleophosmin (NPM1) mutations in acute myeloid leukemia: an ongoing (cytoplasmic) tale of dueling mutations and duality of molecular genetic testing methodologies.
    Wertheim G; Bagg A
    J Mol Diagn; 2008 May; 10(3):198-202. PubMed ID: 18403611
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cell signaling in putative leukemic stem cells and blast population in acute myeloid leukemia.
    Garg S; Shanmukhaiah C; Ghosh K; Madkaikar M
    Leuk Lymphoma; 2016 Sep; 57(9):2195-8. PubMed ID: 26700494
    [No Abstract]   [Full Text] [Related]  

  • 57. Targeting acute myeloid leukemia CD34
    Lei H; Yang L; Zhou L; Tong Y; Wu Y
    Leuk Res; 2018 Sep; 72():71-73. PubMed ID: 30103203
    [No Abstract]   [Full Text] [Related]  

  • 58. Six1 regulates leukemia stem cell maintenance in acute myeloid leukemia.
    Chu Y; Chen Y; Li M; Shi D; Wang B; Lian Y; Cheng X; Wang X; Xu M; Cheng T; Shi J; Yuan W
    Cancer Sci; 2019 Jul; 110(7):2200-2210. PubMed ID: 31050834
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cytosine methylation changes during normal hematopoiesis and in acute myeloid leukemia.
    Lübbert M; Mertelsmann R; Herrmann F
    Leukemia; 1997 Mar; 11 Suppl 1():S12-8. PubMed ID: 9130686
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of DNMT3A, TET2, and IDH1/2 mutations in pre-leukemic stem cells in acute myeloid leukemia.
    Chan SM; Majeti R
    Int J Hematol; 2013 Dec; 98(6):648-57. PubMed ID: 23949914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.